PTGX icon

Protagonist Therapeutics
PTGX

Overview Fund Activity

34 hedge funds and large institutions have $145M invested in Protagonist Therapeutics in 2016 Q3 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
34
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$45M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$33.4M
3
CAM
3
Cormorant Asset Management
Massachusetts
$16.9M
4
RCM
4
RA Capital Management
Massachusetts
$15.9M
5
BI
5
BVF Inc
California
$7.92M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
NFA
26
Nationwide Fund Advisors
Ohio
$44K +$44K +2,101 New
Deutsche Bank
27
Deutsche Bank
Germany
$26K +$26K +1,270 New
UBS Group
28
UBS Group
Switzerland
$23K +$23K +1,069 New
Citigroup
29
Citigroup
New York
$13K +$13K +621 New
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$5.73K +$5.73K +271 New
Creative Planning
31
Creative Planning
Kansas
$4K +$4K +177 New
Morgan Stanley
32
Morgan Stanley
New York
$4K +$4K +200 New
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$4K +$4K +200 New
TCIM
34
TIAA CREF Investment Management
New York
$213 +$213 +10,093 New
1
2